Research uncovers molecule's role in inhibiting organ rejection

06/23/2008 | Forbes

Scientists found that an immune molecule known as HLA-G dimer can help prevent organ- and tissue-transplant rejection in patients by binding to its inhibitory receptor ILT4 to activate a signaling pathway in which immune molecules IL-6 and STAT3 play a role. They believe that boosting the molecule's mechanism can curb immune activity in patients with autoimmune disorders and organ transplants.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Associate Manager, Regulatory Affairs
Mahwah, NJ
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC